Abstract
Clinical trials of treatments are a priority for emerging infectious disease outbreaks. When we design trials, fit-for-purpose endpoints are crucial, as these will inform decisions on case management, regulatory approval, and priority for public health funding and interventions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have